Before revision: As of 2023, the Lancet opined that in teh UK "focusing on improving screening by upgrading targeted gene panels might be more sensible in the short term.
After revision: As of 2023, the Lancet opined that in the UK "focusing on improving screening by upgrading targeted gene panels might be more sensible in the short term.